The company has reached an agreement with GeneVector to develop and offer specialised services in gene and cell therapies. GeneVector has technology for manufacturing lentiviral vectors to introduce genetic material into cells. The alliance will combine...
EBIT reached CHF 60.4 million, up 6% on the same period last year, while the operating margin rose to 3.4% (vs 3.1% in H1 2025). The order book grew 9.6%, to CHF 8,524 million, and the projected profitability of contracted projects also improved, with a pre-calculated...
Atalaya Mining closed the first half of 2026 with a strong improvement in its results, driven by the favourable copper price and a solid cost performance. The company achieved EBITDA of €126.2 million, up 17% on the same period last year and the highest half-year...
Trafigura has begun the process of selling its entire stake in Atalaya Mining, equivalent to approximately 10.9% of the mining company’s capital. The shareholder, through Urion Investments Holdings Limited, has put 16.8 million shares up for sale via an...
Reig Jofre closed the first half of 2026 with revenue of €168.5 million, up 1% year-on-year, and EBITDA of €17.9 million, 27% higher than in the same period of 2025. The EBITDA margin reached 10.7% (8.5% in H1 2026), driven by strong performance in the osteoarticular...
Grupo Baviera is maintaining its growth pace, supported by strong performance in its main markets and the expansion of its clinic network. The company continues to record positive growth in both laser and intraocular surgery, while improved efficiency and cost control...
